Visiting Professors

David Engelberg

Biochemistry

Prof David Engelberg received his PhD in 1991 in Biological Chemistry from HUJ, and was a Principal Investigator at MMID2 programme. He is currently the Principal Investigator at MLID at SHARE. He holds a position of Professor of biochemistry at the Department of Biological Chemistry at the Alexander Silberman Institute of Life Science, the Hebrew University, Jerusalem, Israel. Prof. Engelberg joined the Dept. of Biological Chemistry of the HUJ in 1995 and has been studying the mechanism of action, the biology and pathology of the MAP kinases p38s and ERKs, which are considered central mediators of inflammation and cancer, respectively. His research group was the first to isolate intrinsically active variants of these enzymes. The active variants are becoming powerful tools for investigating structure-function relationships of MAPK enzymes, as well as inflammation and cancer.